Business Wire

MindMed to Participate at September Investor Conferences

NEW YORK--(BUSINESS WIRE)--$MNMD--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today

More